Kincell Bio

Pharmaceutical Manufacturing • 20 TW Alexander Dr, Suite 130, United States • 51-100 Employees

Company overview

Headquarters	20 TW Alexander Dr, Suite 130, Durham, NC 27703, US
Website	kincellbio.com
NAICS	3254
Keywords	Analytical Development, Cmc Support, Tcr-T, Cell Therapy Cdmo, Early Phase Cell Therapy, Manufacturing Gmp Grade, Non-Viral Delivery Technologies, Car-T/Car-M/Car-Nk, Differentiated Ipsc, Tregs
Founded	2023
Employees	51-100
Socials

Key Contacts at Kincell Bio

Mark Bamforth

Ceo And Board Chair

Bruce Thompson

Chief Technology Officer

Randy Elderkin

Senior Director Of Engineering And Validation

Robert Moder

Director Of Quality Assurance

Joshua O'Bryant

Associate Director, Quality Assurance

Roger Herr

Director Analytical Development

Michael Lewis

Associate Director, Supply Chain

Kincell Bio Email Formats

Kincell Bio uses 2 email formats. The most common is {first initial} (e.g., j@kincellbio.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@kincellbio.com	50%
{first initial}.{last name}	j.doe@kincellbio.com	50%

About Kincell Bio

Kincell Bio partners with innovators to advance autologous and allogeneic cell therapies for patients in need of therapeutic solutions. With manufacturing facilities located in Research Triangle Park, NC, and Gainesville, FL, Kincell Bio is a Cell therapy CDMO with the mission to streamline CMC development, apply expertise in analytical and process development, and facilitate quality-first, reliable GMP supply from early clinical to pivotal studies and product launch. Kincell Bio’s platform offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.

Kincell Bio revenue & valuation

Annual revenue	$6,159,960
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$19,800,000
Total funding	$58,000,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Kincell Bio has 37 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Kincell Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-08-26	4	$36,000,000
2025-06-15	1	$22,000,000

Funding Insights

$58,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Kincell Bio is located in 20 TW Alexander Dr, Suite 130, US.

Kincell Bio was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Kincell Bio has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Kincell Bio has raised a total of $58,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.